Cargando…

A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma

PURPOSE: Studies treating adenocarcinoma of the pancreas with gemcitabine alone or in combination with a doublet have demonstrated modest improvements in survival. Recent reports have suggested that using the triple-drug regimen FOLFIRINOX can substantially extend survival in patients with metastati...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Jesus-Acosta, Ana, Oliver, George R., Blackford, Amanda, Kinsman, Katharine, Flores, Edna I., Wilfong, Lalan S., Zheng, Lei, Donehower, Ross C., Cosgrove, David, Laheru, Daniel, Le, Dung T., Chung, Ki, Diaz, Luis A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265723/ https://www.ncbi.nlm.nih.gov/pubmed/21800112 http://dx.doi.org/10.1007/s00280-011-1704-y

Ejemplares similares

Predictors of Response and Survival in Locally Advanced Adenocarcinoma of the Pancreas Following Neoadjuvant GTX with or Without Radiation Therapy
por: Sherman, William H., et al.
Publicado: (2017)

Software para programar radios UHF LCS/LTS 2000/GTX
por: Basañez Álvarez, Keren Happuch
Publicado: (2004)

GtxA from Gallibacterium anatis, a cytolytic RTX-toxin with a novel domain organisation
por: Kristensen, Bodil Marie, et al.
Publicado: (2009)

Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conventional irinotecan-based chemotherapy: a real-world study
por: Gupta, Amol, et al.
Publicado: (2023)

Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma
por: Christenson, Eric S., et al.
Publicado: (2022)

Stability and Safety of Inhibitor Cystine Knot Peptide, GTx1-15, from the Tarantula Spider Grammostola rosea
por: Kimura, Tadashi
Publicado: (2021)

An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma
por: Bever, Katherine M., et al.
Publicado: (2020)

Immune Suppression Induced by Gallibacterium anatis GtxA During Interaction with Chicken Macrophage-Like HD11 Cells
por: Tang, Bo, et al.
Publicado: (2020)

GTX.Digest.VCF: an online NGS data interpretation system based on intelligent gene ranking and large-scale text mining
por: Jiang, Yanhuang, et al.
Publicado: (2019)

GtxA is a virulence factor that promotes a Th2-like response during Gallibacterium anatis infection in laying hens
por: Tang, Bo, et al.
Publicado: (2020)

Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model
por: Walker, Brigham, et al.
Publicado: (2020)

Are Health Literacy and Patient Activation Related to Health Outcomes in Breast Cancer Patients?
por: Kanu, Chisom, et al.
Publicado: (2021)

Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer
por: Yarchoan, Mark, et al.
Publicado: (2017)

Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
por: Hill, Colin S., et al.
Publicado: (2022)

Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
por: Wilbur, H. Catherine, et al.
Publicado: (2023)

Systemic chemotherapy for gastro-oesophagogastric junction adenocarcinoma and stomach adenocarcinoma in a metastatic setting
por: Sanjeevaiah, Aravind, et al.
Publicado: (2020)

Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapy
por: Bhamidipati, D., et al.
Publicado: (2021)

Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer
por: Shrestha, Bikram, et al.
Publicado: (2017)

A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours
por: Wilky, B A, et al.
Publicado: (2015)

A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study)
por: Wang-Gillam, Andrea, et al.
Publicado: (2014)

Real-Life Results of Palliative Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma
por: Varzaru, Bianca, et al.
Publicado: (2023)

Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study
por: Mokadem, I., et al.
Publicado: (2019)

A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy
por: Atiq, Saad, et al.
Publicado: (2021)

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
por: Dalton, James T., et al.
Publicado: (2011)

Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma
por: De Jesus-Acosta, Ana, et al.
Publicado: (2019)

Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR)
por: Le, Dung T, et al.
Publicado: (2015)

Durable clinical benefit to trastuzumab and chemotherapy in a patient with metastatic colon adenocarcinoma harboring ERBB2 amplification
por: Disel, Umut, et al.
Publicado: (2015)

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
por: Hu, Jing, et al.
Publicado: (2011)

Metastatic Prostatic Ductal Adenocarcinoma Successfully Treated with Docetaxel Chemotherapy: A Case Report
por: Fujiwara, Ryo, et al.
Publicado: (2015)

Chemotherapy of metastatic hepatoid adenocarcinoma: Literature review and two case reports with cisplatin etoposide
por: Simmet, Victor, et al.
Publicado: (2018)

Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
por: Cheong, E. Von, et al.
Publicado: (2021)

Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma
por: GÜRLER, Fatih, et al.
Publicado: (2022)

The Efficacy of Paclitaxel and Cisplatin Combination Chemotherapy for the Treatment of Metastatic or Recurrent Gastric Cancer: a Multicenter Phase II Study
por: Shin, Sang Joon, et al.
Publicado: (2005)

Phase 1 Study of ABT‐751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer
por: Rudek, Michelle A., et al.
Publicado: (2016)

Cardiac Tamponade as the Initial Presentation of Metastatic Esophageal Adenocarcinoma
por: Flores Castro, Jose Amadeo, et al.
Publicado: (2021)

Metastatic Thymic Adenocarcinoma from Colorectal Cancer
por: Lee, Mina, et al.
Publicado: (2015)

Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients
por: Ryan, John F., et al.
Publicado: (2018)

Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
por: Verwimp, J, et al.
Publicado: (2010)

Clear-Cell Adenocarcinoma of Vesical Origin: A Case Study of Metastatic Disease Treated with Chemotherapy
por: Pena Álvarez, Carolina, et al.
Publicado: (2010)

Gastric adenocarcinoma is concurrent with metastatic neuroendocrine cancer treated with nivolumab and chemotherapy: A case report
por: Yan, Bing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_79saovq7svkq8roi0oh39tbdhl